Cite
APA Citation
Terui, Y., Rai, S., Izutsu, K., Yamaguchi, M., Takizawa, J., Kuroda, J., Ishikawa, T., Kato, K., Suehiro, Y., Fukuhara, N., Ohmine, K., Goto, H., Yamamoto, K., Kanemura, N., Ueda, Y., Ishizawa, K., Kumagai, K., Kawasaki, A., Saito, T., Hashizume, M., & Shibayama, H. (2021). a phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma. Cancer science, 112(7), 2845–2854. http://access.bl.uk/ark:/81055/vdc_100133931939.0x00001d